Genomic Characterization of Preclinical Prostate Cancer Cell Line Models.

Autor: Beatson, Erica L.¹ (AUTHOR), Risdon, Emily N.¹ (AUTHOR), Napoli, Giulia C.¹ (AUTHOR) dkprice@nih.gov, Price, Douglas K.¹ (AUTHOR), Chau, Cindy H.¹ (AUTHOR), Figg, William D.¹ (AUTHOR) figgw@mail.nih.gov

Publikováno v: International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 11, p6111. 19p.

Navigating the oncology drug discovery and development process with programmes supported by the National Institutes of Health.

Autor: Arisa, Oluwatobi T¹ (AUTHOR), Beatson, Erica L² (AUTHOR), Reno, Annieka¹ (AUTHOR), Chau, Cindy H² (AUTHOR), Aurigemma, Rosemarie³ (AUTHOR), Steeg, Patricia S^4,5 (AUTHOR), Figg, William D^1,2,5 (AUTHOR)

Publikováno v: Lancet Oncology. Dec2024, Vol. 25 Issue 12, pe685-e693. 9p.

PARP inhibitors on the move in prostate cancer: spotlight on Niraparib & update on PARP inhibitor combination trials

Autor: Beatson, Erica L, Chau, Cindy H, Price, Douglas K, Figg, William D

Publikováno v: Am J Clin Exp Urol

PARP inhibitors were recently introduced as a novel targeted therapy for biomarker positive metastatic castration resistant prostate cancer (mCRPC) patients, a population that inevitably acquires resistance to existing standard care regimens. Olapari

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmc_________::61595819792b0f8ffab96cb3200dc8c5
https://europepmc.org/articles/PMC9428566/

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PARP inhibitors on the move in prostate cancer: spotlight on Niraparib & update on PARP inhibitor combination trials.

Autor: Beatson EL; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health Bethesda, MD, USA., Chau CH; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health Bethesda, MD, USA., Price DK; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health Bethesda, MD, USA., Figg WD; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health Bethesda, MD, USA.

Publikováno v: American journal of clinical and experimental urology [Am J Clin Exp Urol] 2022 Aug 15; Vol. 10 (4), pp. 252-257. Date of Electronic Publication: 2022 Aug 15 (Print Publication: 2022).